{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:08:48Z","timestamp":1787162928075,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vascn.2016.05.003","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:24:34Z","timestamp":1463185474000},"page":"240-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"special_numbering":"C","title":["Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging"],"prefix":"10.1016","volume":"81","author":[{"given":"Graham T.","family":"Dempsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuram W.","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Atwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"McNeish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Kralj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2016.05.003_bb0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hec.1454","article-title":"Spending on new drug development1","volume":"19","author":"Adams","year":"2010","journal-title":"Health Economics"},{"key":"10.1016\/j.vascn.2016.05.003_bb0010","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nature Methods"},{"key":"10.1016\/j.vascn.2016.05.003_bb0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/scd.2007.0280","article-title":"In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes","volume":"18","author":"Caspi","year":"2009","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.vascn.2016.05.003_bb0020","first-page":"745","article-title":"Comprehensive in vitro proarrhythmia assay, a novel in vitro\/in silico paradigm to detect ventricular proarrhythmic liability: A visionary 21st century initiative","volume":"13","author":"Cavero","year":"2014","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1016\/j.vascn.2016.05.003_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature12354","article-title":"Ultrasensitive fluorescent proteins for imaging neuronal activity","volume":"499","author":"Chen","year":"2013","journal-title":"Nature"},{"issue":"Pt 1","key":"10.1016\/j.vascn.2016.05.003_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1469-7793.2000.00171.x","article-title":"Simultaneous maps of optical action potentials and calcium transients in guinea-pig hearts: Mechanisms underlying concordant alternans","volume":"529","author":"Choi","year":"2000","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0035","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0026-895X(24)13071-4","article-title":"HERG and KvLQT1\/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers","volume":"54","author":"Chouabe","year":"1998","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bjp.0706140","article-title":"Pentamidine reduces hERG expression to prolong the QT interval","volume":"145","author":"Cordes","year":"2005","journal-title":"British Journal of Pharmacology"},{"issue":"Suppl. D","key":"10.1016\/j.vascn.2016.05.003_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/eurheartj\/6.suppl_D.115","article-title":"Possible mechanisms of the arrhythmias in the long QT syndrome","volume":"6","author":"Coumel","year":"1985","journal-title":"European Heart Journal"},{"key":"10.1016\/j.vascn.2016.05.003_bb0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200225040-00004","article-title":"Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: An overview","volume":"25","author":"De Ponti","year":"2002","journal-title":"Drug Safety: an International Journal of Medical Toxicology and Drug Experience"},{"key":"10.1016\/j.vascn.2016.05.003_bb0055","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1006\/jmcc.2000.1128","article-title":"Differentiation of cardiomyocytes in floating embryoid bodies is comparable to fetal cardiomyocytes","volume":"32","author":"Doevendans","year":"2000","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.vascn.2016.05.003_bb9000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpj.2014.11.008","article-title":"Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density","volume":"108","author":"Du","year":"2015","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.vascn.2016.05.003_bb0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pbiomolbio.2005.10.003","article-title":"Macroscopic optical mapping of excitation in cardiac cell networks with ultra-high spatiotemporal resolution","volume":"92","author":"Entcheva","year":"2006","journal-title":"Progress in Biophysics and Molecular Biology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-2999(99)00614-7","article-title":"Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion","volume":"383","author":"Faivre","year":"1999","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0070","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.RES.73.5.914","article-title":"Microscopic conduction in cultured strands of neonatal rat heart cells measured with voltage-sensitive dyes","volume":"73","author":"Fast","year":"1993","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0075","first-page":"61133","volume":"70","year":"2005","journal-title":"Federal Register"},{"key":"10.1016\/j.vascn.2016.05.003_bb0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00001573-199501000-00009","article-title":"Recent insights into the regulation of cardiac Ca2+ flux during perinatal development and in cardiac failure","volume":"10","author":"Fisher","year":"1995","journal-title":"Current Opinion in Cardiology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.vascn.2014.09.005","article-title":"Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents","volume":"70","author":"Gibson","year":"2014","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2016.05.003_bb0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.taap.2015.07.024","article-title":"High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays","volume":"288","author":"Gilchrist","year":"2015","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pharmthera.2010.08.008","article-title":"An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation","volume":"129","author":"Gintant","year":"2011","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.003_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2133\/dmpk.DMPK-10-RV-062","article-title":"Mechanisms of drug toxicity and relevance to pharmaceutical development","volume":"26","author":"Guengerich","year":"2011","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.vascn.2016.05.003_bb0105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/toxsci\/kft205","article-title":"Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model","volume":"136","author":"Guo","year":"2013","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2016.05.003_bb0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000329966","article-title":"The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts","volume":"27","author":"Guo","year":"2011","journal-title":"Cellular Physiology and Biochemistry: Internation Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0115","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vascn.2006.05.001","article-title":"ILSI-HESI cardiovascular safety subcommittee initiative: Evaluation of three non-clinical models of QT prolongation","volume":"54","author":"Hanson","year":"2006","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2016.05.003_bb0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.vascn.2006.02.013","article-title":"Can optical recordings of membrane potential be used to screen for drug-induced action potential prolongation in single cardiac myocytes?","volume":"54","author":"Hardy","year":"2006","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2016.05.003_bb0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kft113","article-title":"Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays","volume":"134","author":"Harris","year":"2013","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2016.05.003_bb0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0008-6363(00)00119-X","article-title":"The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology","volume":"47","author":"Haverkamp","year":"2000","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.RES.0000080317.92718.99","article-title":"Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization","volume":"93","author":"He","year":"2003","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2125.2008.03249.x","article-title":"Cisapride and ventricular arrhythmia","volume":"66","author":"Hennessy","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/CIRCRESAHA.111.247494","article-title":"Optical imaging of voltage and calcium in cardiac cells & tissues","volume":"110","author":"Herron","year":"2012","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.vascn.2013.05.005","article-title":"Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: Effects of reference compounds","volume":"68","author":"Himmel","year":"2013","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2016.05.003_bb0155","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nmeth.3000","article-title":"All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins","volume":"11","author":"Hochbaum","year":"2014","journal-title":"Nature Methods"},{"key":"10.1016\/j.vascn.2016.05.003_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.vascn.2013.05.004","article-title":"Preclinical QT safety assessment: Cross-species comparisons and human translation from an industry consortium","volume":"69","author":"Holzgrefe","year":"2014","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2016.05.003_bb0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1254\/jphs.11038FP","article-title":"Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells","volume":"117","author":"Honda","year":"2011","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.vascn.2016.05.003_bb0170","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fphys.2014.00344","article-title":"Simultaneous mapping of membrane voltage and calcium in zebrafish heart in vivo reveals chamber-specific developmental transitions in ionic currents","volume":"5","author":"Hou","year":"2014","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0175","article-title":"Automated video-based analysis of contractility and calcium flux in human iPS-derived cardiomyocytes cultured over different spatial scales","author":"Huebsch","year":"2014","journal-title":"Tissue Engineering. Part C, Methods"},{"key":"10.1016\/j.vascn.2016.05.003_bb0180","author":"ICHS7B"},{"key":"10.1016\/j.vascn.2016.05.003_bb0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature09747","article-title":"Modelling the long QT syndrome with induced pluripotent stem cells","volume":"471","author":"Itzhaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vascn.2016.05.003_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphar.2011.00042","article-title":"Screening action potentials: The power of light","volume":"2","author":"Kaestner","year":"2011","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0195","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCRESAHA.114.303475","article-title":"Genetically encoded Ca2+ indicators in cardiac myocytes","volume":"114","author":"Kaestner","year":"2014","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0200","first-page":"53","article-title":"Molecular genetics of long QT syndrome","volume":"50","author":"Keating","year":"1995","journal-title":"Society of General Physiologists Series"},{"key":"10.1016\/j.vascn.2016.05.003_bb0205","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: Superior to the HERG model in predicting Torsade de Pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2016.05.003_bb0210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.104.073692","article-title":"Pentamidine-induced long QT syndrome and block of hERG trafficking","volume":"312","author":"Kuryshev","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2016.05.003_bb0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.vascn.2016.05.003_bb0220","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/CIRCRESAHA.111.262535","article-title":"Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers","volume":"110","author":"Lee","year":"2012","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0225","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s12015-011-9273-3","article-title":"Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes","volume":"7","author":"Lee","year":"2011","journal-title":"Stem Cell Reviews"},{"key":"10.1016\/j.vascn.2016.05.003_bb0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.stemcr.2014.01.003","article-title":"Rapid cellular phenotyping of human pluripotent stem cell-derived cardiomyocytes using a genetically encoded fluorescent voltage sensor","volume":"2","author":"Leyton-Mange","year":"2014","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.vascn.2016.05.003_bb0235","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1634\/stemcells.2007-0549","article-title":"Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: Insights for driven maturation","volume":"25","author":"Liu","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.vascn.2016.05.003_bb0240","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1113\/jphysiol.2010.197715","article-title":"Sarcoplasmic reticulum and L-type Ca(2)(+) channel activity regulate the beat-to-beat stability of calcium handling in human atrial myocytes","volume":"589","author":"Llach","year":"2011","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0245","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bjp.2008.191","article-title":"Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B guidelines","volume":"154","author":"Lu","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0250","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: Electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0255","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.1215595110","article-title":"Mechanism of voltage-sensitive fluorescence in a microbial rhodopsin","volume":"110","author":"Maclaurin","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vascn.2016.05.003_bb0260","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.111.045146","article-title":"Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior","volume":"125","author":"Mandel","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.003_bb0265","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/toxsci\/kfs309","article-title":"Pharmacoelectrophysiology of viral-free induced pluripotent stem cell-derived human cardiomyocytes","volume":"131","author":"Mehta","year":"2013","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2016.05.003_bb0270","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1073\/pnas.1120694109","article-title":"Optically monitoring voltage in neurons by photo-induced electron transfer through molecular wires","volume":"109","author":"Miller","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vascn.2016.05.003_bb0275","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1158\/1078-0432.CCR-06-1715","article-title":"HDAC inhibitors and cardiac safety","volume":"13","author":"Molife","year":"2007","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0280","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/01.CIR.0000068356.38592.68","article-title":"Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells","volume":"107","author":"Mummery","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.003_bb0285","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1254\/jphs.13248FP","article-title":"Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: Multi-site validation study","volume":"124","author":"Nakamura","year":"2014","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.vascn.2016.05.003_bb0290","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0295","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nature09249","article-title":"Wnt11 patterns a myocardial electrical gradient through regulation of the L-type Ca(2+) channel","volume":"466","author":"Panakova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.vascn.2016.05.003_bb0300","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1038\/srep06125","article-title":"Optical mapping of optogenetically shaped cardiac action potentials","volume":"4","author":"Park","year":"2014","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2016.05.003_bb0305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vascn.2010.01.014","article-title":"The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes","volume":"61","author":"Peng","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2016.05.003_bb0310","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/toxsci\/kfs282","article-title":"Comparative gene expression profiling in human-induced pluripotent stem cell-derived cardiocytes and human and cynomolgus heart tissue","volume":"131","author":"Puppala","year":"2013","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2016.05.003_bb0315","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1113\/jphysiol.2013.256115","article-title":"Atrial selectivity of antiarrhythmic drugs","volume":"591","author":"Ravens","year":"2013","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0320","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0325","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yjmcc.2011.04.012","article-title":"Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells","volume":"51","author":"Ren","year":"2011","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0330","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.biomaterials.2015.01.067","article-title":"Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro-correlation between contraction force and electrophysiology","volume":"51","author":"Ribeiro","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.vascn.2016.05.003_bb0335","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.94.8.1996","article-title":"Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS foundation task force on LQTS","volume":"94","author":"Roden","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2016.05.003_bb0340","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the cardiac safety research consortium","volume":"167","author":"Sager","year":"2014","journal-title":"American Heart Journal"},{"key":"10.1016\/j.vascn.2016.05.003_bb0345","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.191.4226.485","article-title":"Merocyanine 540 as an optical probe of transmembrane electrical activity in the heart","volume":"191","author":"Salama","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.vascn.2016.05.003_bb0350","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.vascn.2016.05.003_bb0355","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.bjp.0705879","article-title":"Ranolazine: Ion-channel-blocking actions and in vivo electrophysiological effects","volume":"142","author":"Schram","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0360","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature06800","article-title":"Stem-cell therapy for cardiac disease","volume":"451","author":"Segers","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vascn.2016.05.003_bb0365","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/CIRCRESAHA.114.302938","article-title":"Imaging Ca2+ nanosparks in heart with a new targeted biosensor","volume":"114","author":"Shang","year":"2014","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0370","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00005344-200408000-00008","article-title":"Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes","volume":"44","author":"Song","year":"2004","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.vascn.2016.05.003_bb0375","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drudis.2008.11.009","article-title":"The future of drug safety testing: Expanding the view and narrowing the focus","volume":"14","author":"Stevens","year":"2009","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.vascn.2016.05.003_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.0000082767.38055.03","article-title":"Electrophysiological profiling of cardiomyocytes in embryonic bodies derived from human embryonic stem cells: Therapeutic implications","volume":"93","author":"Vanderlaan","year":"2003","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2016.05.003_bb0385","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nm.3545","article-title":"Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies","volume":"20","author":"Wang","year":"2014","journal-title":"Nature Medicine"},{"key":"10.1016\/j.vascn.2016.05.003_bb0390","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/00498250110054632","article-title":"Pharmacokinetic\/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog","volume":"31","author":"Webster","year":"2001","journal-title":"Xenobiotica"},{"key":"10.1016\/j.vascn.2016.05.003_bb0395","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF00373887","article-title":"Optical multisite monitoring of cell excitation phenomena in isolated cardiomyocytes","volume":"430","author":"Windisch","year":"1995","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.vascn.2016.05.003_bb0400","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09855","article-title":"Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome","volume":"471","author":"Yazawa","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vascn.2016.05.003_bb9001","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbrc.2009.07.052","article-title":"The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells","volume":"387","author":"Yokoo","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.vascn.2016.05.003_bb0405","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-3495(98)77782-3","article-title":"Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature","volume":"74","author":"Zhou","year":"1998","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.vascn.2016.05.003_bb0410","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0002-9149(78)90853-6","article-title":"New antiarrhythmic agents: Amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil","volume":"41","author":"Zipes","year":"1978","journal-title":"The American Journal of Cardiology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871916300442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871916300442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:01:43Z","timestamp":1761004903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871916300442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":84,"alternative-id":["S1056871916300442"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2016.05.003","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2016.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}